# Hikma Pharmaceuticals USA INC. – FDA Inspection, Sep 19, 2017

Source: https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/b413184b-50e8-42c5-a73c-43cfbf22c1c8
Source feed: FDA_Inspections

> FDA inspection 1028066 of Hikma Pharmaceuticals USA INC., September 19, 2017. Classification: No Action Indicated (NAI). 27 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1028066
- Company Name: Hikma Pharmaceuticals USA INC.
- Inspection Date: 2017-09-19
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1285748 - 2026-09-18
- FDA Inspection 1303412 - 2026-04-30
- [FDA Inspection 1238509 - 2025-01-17](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/be288e60-3b18-493f-bcd2-c5d2f1ca4059)
- FDA Inspection 1243797 - 2024-07-23
- FDA Inspection 1182363 - 2022-09-15

## Related Officers

- [Andrew J. Barrowcliff](https://www.keypedia.com/people/andrew-j-barrowcliff/5dd49407-9028-4c84-9e86-3f0b6239538e)
- [FDA Associated Person](https://www.keypedia.com/people/ucheabuchi-c-chudi-nwankwor/18b01d08-3cfd-4ace-97b2-5f54b6427661)

Company: https://www.keypedia.com/companies/hikma-pharmaceuticals-usa-inc/6289cb89-1444-49a0-91b0-75a04e5152eb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c